Search Results

There are 7422 results for: content related to: Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients

  1. You have free access to this content
    Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks

    British Journal of Clinical Pharmacology

    Volume 77, Issue 4, April 2014, Pages: 715–728, Laure Elens, Rachida Bouamar, Nauras Shuker, Dennis A. Hesselink, Teun van Gelder and Ron H. N. van Schaik

    Version of Record online : 20 MAR 2014, DOI: 10.1111/bcp.12253

  2. Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects

    Clinical Pharmacology & Therapeutics

    Volume 80, Issue 6, December 2006, Pages: 646–656, Kyoung-Ah Kim, Pil-Whan Park, Ock-Je Lee, Sang-Hyun Choi, Bon Hong Min, Kyung-Ho Shin, Boe-Gwun Chun, Jae-Gook Shin and Ji-Young Park

    Version of Record online : 15 DEC 2006, DOI: 10.1016/j.clpt.2006.09.009

  3. You have free access to this content
    Influence of CYP3A5 Genetic Polymorphism on Tacrolimus Daily Dose Requirements and Acute Rejection in Renal Graft Recipients

    Basic & Clinical Pharmacology & Toxicology

    Volume 103, Issue 6, December 2008, Pages: 546–552, Lina Quteineh, Céline Verstuyft, Valerie Furlan, Antoine Durrbach, Alexia Letierce, Sophie Ferlicot, Anne-Marie Taburet, Bernard Charpentier and Laurent Becquemont

    Version of Record online : 14 OCT 2008, DOI: 10.1111/j.1742-7843.2008.00327.x

  4. CYP3A5 and CYP3A4 but not MDR1 Single-nucleotide Polymorphisms Determine Long-term Tacrolimus Disposition and Drug-related Nephrotoxicity in Renal Recipients

    Clinical Pharmacology & Therapeutics

    Volume 82, Issue 6, December 2007, Pages: 711–725, D R J Kuypers, H de Jonge, M Naesens, E Lerut, K Verbeke and Y Vanrenterghem

    Version of Record online : 9 MAY 2007, DOI: 10.1038/sj.clpt.6100216

  5. Influence of CYP3A5 Genotype on the Pharmacokinetics and Pharmacodynamics of the Cytochrome P4503A Probes Alfentanil and Midazolam

    Clinical Pharmacology & Therapeutics

    Volume 82, Issue 4, October 2007, Pages: 410–426, E D Kharasch, A Walker, N Isoherranen, C Hoffer, P Sheffels, K Thummel, D Whittington and D Ensign

    Version of Record online : 6 JUN 2007, DOI: 10.1038/sj.clpt.6100237

  6. Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: Age dependency and pharmacological interaction with steroids

    Pediatric Transplantation

    Volume 15, Issue 5, August 2011, Pages: 525–532, Jorge R. Ferraris, Pablo F. Argibay, Lucas Costa, Graciela Jimenez, Paula A. Coccia, Lidia F. R. Ghezzi, Verónica Ferraris, Waldo H. Belloso, María A. Redal and Julián M. Larriba

    Version of Record online : 28 JUN 2011, DOI: 10.1111/j.1399-3046.2011.01513.x

  7. Effect of Polymorphic CYP3A5 Genotype on the Single-Dose Simvastatin Pharmacokinetics in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 47, Issue 1, January 2007, Pages: 87–93, Dr Kyoung-Ah Kim, Dr Pil-Whan Park, Dr Ock-Je Lee, Dr Dong-Kyun Kang and Dr Ji-Young Park

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006295063

  8. You have free access to this content
    Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation

    Transplant International

    Volume 25, Issue 4, April 2012, Pages: 471–480, Guillermo Gervasini, Montserrat Garcia, Rosa María Macias, Juan Jose Cubero, Francisco Caravaca and Julio Benitez

    Version of Record online : 28 FEB 2012, DOI: 10.1111/j.1432-2277.2012.01446.x

  9. Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects

    Clinical Pharmacology & Therapeutics

    Volume 79, Issue 6, June 2006, Pages: 590–599, Ji-Young Park, Kyoung-Ah Kim, Pil-Whan Park, Ock-Je Lee, Dong-Kyun Kang, Ji-Hong Shon, Kwang-Hyun Liu and Jae-Gook Shin

    Version of Record online : 2 MAY 2006, DOI: 10.1016/j.clpt.2006.02.008

  10. Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

    Clinical Pharmacology & Therapeutics

    Volume 74, Issue 3, September 2003, Pages: 245–254, Dennis A. Hesselink, Ron H. N. van Schaik, Ilse P. van der Heiden, Marloes van der Werf, Peter J. H. Smak Gregoor, Jan Lindemans, Willem Weimar and Teun van Gelder

    Version of Record online : 17 SEP 2003, DOI: 10.1016/S0009-9236(03)00168-1

  11. Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients

    Clinical Pharmacology & Therapeutics

    Volume 86, Issue 6, December 2009, Pages: 609–618, W Zhao, V Elie, G Roussey, K Brochard, P Niaudet, V Leroy, C Loirat, P Cochat, S Cloarec, J L André, F Garaix, A Bensman, M Fakhoury and E Jacqz-Aigrain

    Version of Record online : 28 OCT 2009, DOI: 10.1038/clpt.2009.210

  12. You have free access to this content
    Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

    Clinical Pharmacology & Therapeutics

    Volume 98, Issue 1, July 2015, Pages: 19–24, KA Birdwell, B Decker, JM Barbarino, JF Peterson, CM Stein, W Sadee, D Wang, AA Vinks, Y He, JJ Swen, JS Leeder, RHN van Schaik, KE Thummel, TE Klein, KE Caudle and IAM MacPhee

    Version of Record online : 3 JUN 2015, DOI: 10.1002/cpt.113

  13. Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis

    Journal of Clinical Pharmacy and Therapeutics

    Volume 36, Issue 5, October 2011, Pages: 614–624, X.-J. Shi, F. Geng, Z. Jiao, X.-Y. Cui, X.-Y. Qiu and M.-K. Zhong

    Version of Record online : 5 OCT 2010, DOI: 10.1111/j.1365-2710.2010.01206.x

  14. CYP3A5 Genotype and Midazolam Clearance in Australian Patients Receiving Chemotherapy

    Clinical Pharmacology & Therapeutics

    Volume 75, Issue 6, June 2004, Pages: 529–538, Mark Wong, Rosemary L. Balleine, Michael Collins, Christopher Liddle, Christine L. Clarke and Howard Gurney

    Version of Record online : 28 JUN 2004, DOI: 10.1016/j.clpt.2004.02.005

  15. Pharmacogenetic Pathway Analysis of Docetaxel Elimination

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 2, February 2009, Pages: 155–163, SD Baker, J Verweij, GA Cusatis, RH van Schaik, S Marsh, SJ Orwick, RM Franke, S Hu, EG Schuetz, V Lamba, WA Messersmith, AC Wolff, MA Carducci and A Sparreboom

    Version of Record online : 28 MAY 2008, DOI: 10.1038/clpt.2008.95

  16. Identification and Phenotype Characterization of Two CYP3A Haplotypes Causing Different Enzymatic Capacity in Fetal Livers

    Clinical Pharmacology & Therapeutics

    Volume 77, Issue 4, April 2005, Pages: 259–270, Cristina Rodríguez-Antona, Mary Jande, Anders Rane and Magnus Ingelman-Sundberg

    Version of Record online : 2 APR 2005, DOI: 10.1016/j.clpt.2004.11.003

  17. You have free access to this content
    Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients

    British Journal of Clinical Pharmacology

    Volume 78, Issue 2, August 2014, Pages: 364–372, Diego Alberto C. Cusinato, Riccardo Lacchini, Elen A. Romao, Miguel Moysés-Neto and Eduardo B. Coelho

    Version of Record online : 21 JUL 2014, DOI: 10.1111/bcp.12345

  18. In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 3, September 2012, Pages: 366–375, H de Jonge, H de Loor, K Verbeke, Y Vanrenterghem and D R Kuypers

    Version of Record online : 8 AUG 2012, DOI: 10.1038/clpt.2012.109

  19. Genotype-phenotype Associations of Cytochrome P450 3A4 and 3A5 Polymorphism with Midazolam Clearance in Vivo

    Clinical Pharmacology & Therapeutics

    Volume 77, Issue 5, May 2005, Pages: 373–387, Ping He, Michael H. Court, David J. Greenblatt and Lisa L. von Moltke

    Version of Record online : 16 MAY 2005, DOI: 10.1016/j.clpt.2004.11.112

  20. You have free access to this content
    CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

    American Journal of Transplantation

    Volume 6, Issue 11, November 2006, Pages: 2706–2713, V. Haufroid, P. Wallemacq, V. VanKerckhove, L. Elens, M. De Meyer, D. C. Eddour, J. Malaise, D. Lison and M. Mourad

    Version of Record online : 29 AUG 2006, DOI: 10.1111/j.1600-6143.2006.01518.x